Clinical Trial Update: Cholesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing cholesterol-lowering effects of nutraceuticals versus ezetimibe in statin-intolerant patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Nutraceuticals

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN